Please assess the completion status of the following clinical trial:

Trial Title: Impact of Opioids on Heart Rate During Rapid Sequence Intubation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patient over 65 years old and any possible ASA OR Patient aged 55 to 65 years old with an ASA ≥ 3,~* Patient undergoing surgery (urgent or scheduled), requiring general anesthesia in rapid sequence, because considered to have a full stomach, i.e. with: gastro-oesophageal pathology or gastroparesis or a history of bariatric surgery or food intake within two hours for liquids and within six hours for solids,~* Patient informed of the study who gave their written consent before starting the study procedures,~* Patient affiliated to a French social security system.~Exclusion Criteria:~* Patient \< 55 years old,~* Patient on beta blockers,~* Atrial fibrillation or other rhythm or conduction disturbances,~* Patient in hemodynamic failure and/or on catecholamines before the start of GA,~* Patient having a history of stroke, hemorrhagic and/or ischemic and/or transient~* Combination with opioid agonists-antagonists or partial opioid antagonists~* Known hypersensitivity to one of the study drugs or to opioids,~* History of difficult intubation,~* Patient under guardianship, curatorship or deprived of liberty,~* Patient participating in another interventional clinical research,~* Patient under AME (State Medical Aid)

- Gender: ALL
- Minimum Age: 55 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group A (placebo + remifentanil) (Type: EXPERIMENTAL): None
- Group B (sufentanil + placebo) (Type: EXPERIMENTAL): None
- Group C (placebo + placebo) (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).